The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-04-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-06-229542PMID 20194896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants.

  2010cited by this paper
• Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients

  2009cited by this paper
• New insights to the MLL recombinome of acute leukemias

  2009cited by this paper
• H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

  2008cited by this paper
• Combined effects of the two reciprocal t(4;11) fusion proteins MLL·AF4 and AF4·MLL confer resistance to apoptosis, cell cycling capacity and growth transformation

  2007cited by this paper
• The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.

  2007cited by this paper
• Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4·MLL fusion allele

  2007cited by this paper
• A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.

  2006cited by this paper
• A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology

  2006cited by this paper
• Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.

  2005cited by this paper
• MLL associates specifically with a subset of transcriptionally active target genes.

  2005cited by this paper
• Disruption of Sept6, a Fusion Partner Gene of MLL, Does Not Affect Ontogeny, Leukemogenesis Induced by MLL-SEPT6, or Phenotype Induced by the Loss of Sept4

  2005cited by this paper
• WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.

  2005cited by this paper
• Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein

  2004cited by this paper
• The small oligomerization domain of gephyrin converts MLL to an oncogene.

  2004cited by this paper
• Interaction of AF4 wild-type and AF4·MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?

  2004cited by this paper
• Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization

  2004cited by this paper
• Dimerization of MLL fusion proteins immortalizes hematopoietic cells.

  2003cited by this paper
• MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

  2003cited by this paper
• Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.

  2003cited by this paper
• Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

  2003cited by this paper
• The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21)

  2003cited by this paper
• The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.

  2002cited by this paper
• ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

  2002cited by this paper
• Bethesda proposals for classification of lymphoid neoplasms in mice.

  2002cited by this paper
• The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.

  2001cited by this paper
• Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.

  2000cited by this paper
• A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.

  2000influential reference
• High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein.

  1998cited by this paper
• The Oncogenic Capacity of HRX-ENL Requires the Transcriptional Transactivation Activity of ENL and the DNA Binding Motifs of HRX

  1998cited by this paper
• Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL

  1997cited by this paper
• Exon/intron structure of the human ALL‐1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias

  1996cited by this paper
• An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.

  1996cited by this paper
• Complete exon structure of the ALL1 gene.

  1996cited by this paper
• Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;ll)

  1995cited by this paper
• The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin‐7

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Oncogenic conversion of transcription factors by chromosomal translocations.

  1991cited by this paper
• Translocations, master genes, and differences between the origins of acute and chronic leukemias.

  1991influential reference
• t ( 11 ; 17 ) ( q 23 ; q 21 )

  year unknowncited by this paper

• Evaluation of current mouse in vivo models and advanced in vitro models for leukaemia research.

  2025cites this paper
• Identification of Molecular Subtypes of B-Cell Acute Lymphoblastic Leukemia in Mexican Children by Whole-Transcriptome Analysis

  2025cites this paper
• Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome

  2024cites this paper
• The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae

  2023cites this paper
• Unexpected appearance of KMT2A::MLLT10 fusion transcript in acute myeloid leukemia with t(5;11)(q31;q23.3).

  2023cites this paper
• A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1

  2022cites this paper
• RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4

  2022cites this paper
• KMT2A‐D pathogenicity, prevalence, and variation according to a population database

  2022cites this paper
• MLL-AF4 and a murinized pSer-variant thereof are turning on the nucleolar stress pathway

  2022cites this paper
• A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML

  2022cites this paper
• A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program

  2021cites this paper
• The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11)

  2021cites this paper
• Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

  2021cites this paper
• Rare KMT2A-ELL and Novel ZNF56-KMT2A Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia

  2021cites this paper
• Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates HOXA9 Gene Expression in t(4;11) Leukemia Cells

  2021cites this paper
• Loss of KMT2C reprograms the epigenomic landscape in hPSCs resulting in NODAL overexpression and a failure of hemogenic endothelium specification

  2021cites this paper
• The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis

  2021cites this paper
• Aberrant Activity of Histone–Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis

  2020cites this paper
• The reciprocal world of MLL fusions: A personal view.

  2020cites this paper
• H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells

  2020cites this paper
• Post-transcriptional gene regulation by the RNA binding protein IGF2BP3 is critical for MLL-AF4 mediated leukemogenesis

  2020cites this paper
• MLL fusion proteins and transcriptional control.

  2020cites this paper
• A novel human fetal liver-derived model reveals that MLL-AF4 drives a distinct fetal gene expression program in infant ALL

  2020cites this paper
• Reciprocal ATP5L–KMT2A gene fusion in a paediatric B lymphoblastic leukaemia/lymphoma (B‐ALL) patient

  2020cites this paper
• Learning from mouse models of MLL fusion gene-driven acute leukemia.

  2020cites this paper
• The molecular functions of common and atypical MLL fusion protein complexes.

  2020cites this paper
• DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment

  2019cites this paper
• Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

  2019influential citation
• Acute myeloid leukemia with t(10;11)(p11‐12;q23.3): Results of Russian Pediatric AML registration study

  2019cites this paper
• Deriving an Induced Pluripotent Stem Cell Model of Acute Myeloid Leukemia

  2019cites this paper
• MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)—Current Treatment Options. Is There a Role for CAR-T Cell Therapy?

  2019cites this paper
• Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9

  2019cites this paper
• Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly(I:C), but not to a single maternal immune activation

  2019cites this paper
• The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features

  2019cites this paper
• Exploring Infant Leukemia through Exome Sequencing and an In Vitro Model of Hematopoietic Development

  2019cites this paper
• Another piece of the puzzle added to understand t(4;11) leukemia better

  2019cites this paper
• Relatively favorable prognosis for MLL‐rearranged childhood acute leukemia with reciprocal translocations

  2018cites this paper
• How to effectively treat acute leukemia patients bearing MLL-rearrangements ?

  2018cites this paper
• Two novel fusion genes, AIF1L‐ETV6 and ABL1‐AIF1L, result together with ETV6‐ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin

  2018cites this paper
• Mouse models of MLL leukemia: recapitulating the human disease.

  2017cites this paper
• Congenital neurodevelopmental anomalies in pediatric and young adult cancer

  2017cites this paper
• RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.

  2017cites this paper
• Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research

  2017cites this paper
• Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype

  2017cites this paper
• The MLL recombinome of acute leukemias in 2017

  2017cites this paper
• The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34+ cells

  2017cites this paper
• Molecular Interrogation and Functional Studies of Acute Leukemia

  2017cites this paper
• CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo

  2017cites this paper
• Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia

  2017cites this paper
• MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

  2017cites this paper
• Transcriptional activation by MLL fusion proteins in leukemogenesis.

  2017cites this paper
• Molecular processes involved in B cell acute lymphoblastic leukaemia

  2017cites this paper
• The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34+ cells.

  2017cites this paper
• TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription

  2016cites this paper
• The Relative Contributions of Germline Variation, Epimutation, and Somatic Mutation to Paediatric Leukaemia Predisposition

  2016cites this paper
• Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes*

  2016cites this paper
• Étude des gènes de fusion MLL dans les leucémies aigues humaines

  2016cites this paper
• Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.

  2016influential citation
• Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34+ HSPC But Is Insufficient to Initiate Leukemia.

  2016cites this paper
• MLL-SEPT5 Fusion Transcript in Two de novo Acute Myeloid Leukemia Patients With t(11;22)(q23;q11)

  2016cites this paper
• Taspase1: a 'misunderstood' protease with translational cancer relevance

  2016cites this paper
• University of Birmingham Instructive role of MLL-fusion proteins revealed by a faithful model of t(4;11) proB acute lymphoblastic leukemia

  2016influential citation
• Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer

  2016cites this paper
• Rôle du gène de fusion MLL-ENL dans le développement et le maintien du phénotype leucémique

  2016cites this paper
• Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia

  2016cites this paper
• The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism

  2016cites this paper
• MLL-r Leukemia

  2016cites this paper
• Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis

  2016cites this paper
• DDX6 transfers P-TEFb kinase to the AF4/AF4N (AFF1) super elongation complex.

  2016cites this paper
• Molecular and clinical dissection of infant acute lymphoblastic leukemia

  2016cites this paper
• Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development

  2016cites this paper
• The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma

  2015cites this paper
• AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3

  2015cites this paper
• Hijacked in cancer: the KMT2 (MLL) family of methyltransferases

  2015cites this paper
• DNA Repair and Chromosomal Translocations.

  2015cites this paper
• Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways

  2015cites this paper
• Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia

  2015cites this paper
• Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4–MLL Fusion Protein

  2015cites this paper
• Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells

  2015cites this paper
• Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases.

  2015cites this paper
• AF4 and AF4N protein complexes: recruitment of P-TEFb kinase, their interactome and potential functions.

  2015cites this paper
• MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

  2015cites this paper
• MLL Leukemia and Future Treatment Strategies

  2015cites this paper
• Novel inhibitors for the protease Taspase1

  2015cites this paper
• Leukemic Stem Cells in Acute Lymphoblastic Leukemia

  2015cites this paper
• Cellular and Molecular Basis of KMT2A/MLL Leukaemias: From Transformation Mechanisms to Novel Therapeutic Strategies

  2015cites this paper
• Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

  2015cites this paper
• Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells

  2014cites this paper
• Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation.

  2014cites this paper
• Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL

  2014cites this paper
• Role of the Trithorax (MLL): HOX Axis in HSC Development, Function, and Leukemia

  2014cites this paper
• Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research

  2014cites this paper
• Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.

  2014cites this paper
• FISH analysis of MLL gene rearrangements: detection of the concurrent loss or gain of the 3′ signal and its prognostic significance

  2014cites this paper
• Rare childhood tumours: clinical challenges and genetic alterations

  2014cites this paper
• Hematopoietic StemCells Are Intrinsically Protected against MLL-ENL-Mediated Transformation Graphical Abstract Highlights

  2014cites this paper
• Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins

  2014cites this paper
• FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.

  2013cites this paper
• The Role of the MLL-HOXA9 Axis in Normal and Malignant Hematopoiesis.

  2013cites this paper
• Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia

  2013cites this paper